Replies to post #221496 on Biotech Values

[DewDiligence]

MACK has completed the layoff of all employees—including executive officers. It is now effectively a shell company with some potential milestone payments from Ipsen.

(5/30/19 PR: http://investors.merrimackpharma.com/news-releases/news-release-details/merrimack-pharmaceuticals-announces-completion-strategic-review.)